
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Caliway is dedicated to pioneering small-molecule medications catering to aesthetics and various diseases, tapping into a burgeoning market valued at over $10 billion. Our flagship compound, CBL-514, showcased remarkable efficacy in Phase 2 clinical trials, notably reducing subcutaneous fat by an average of 312mL in treated areas while also demonstrating promising improvements in cellulite without significant systemic side effects. Furthermore, our pipeline boasts CBL-514D, earmarked for addressing Dercums disease, a rare condition characterized by painful lipoma growths. For more information, please visit: Caliway.com.tw/en
Caliway biopharmaceuticals operates in the Pharmaceutical manufacturing industry.
Caliway biopharmaceuticals's revenue is 11m - 100m
Caliway biopharmaceuticals has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.